Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001493152-18-010240)

Filing Details

Accession Number:: 0001493152-18-010240
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-07-19 17:59:21
Reporting Period:: 2018-07-19

Accepted Time:: 2018-07-19 17:59:21
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1695357	Provention Bio Inc.	PRVB	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1743611	Wayne Pisano	C/O Provention Bio, Inc. P.o. Box 666 Oldwick NJ 08858		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.0001 Per Share	Acquisiton	2018-07-19	2,500	$4.00	2,500	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock, Par Value $0.0001	Option (right to buy)	Acquisiton	2018-07-19	128,981	$0.00	128,981	$4.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
128,981		2028-07-19	No	4	A	Direct

Footnotes

The securities were purchased pursuant to an underwritten public offering by the Issuer. The offering closed on July 19, 2018.
The option vests in eight equal semi-annual installments commencing on January 19, 2018 and will become fully vested on July 19, 2022.
The securities were granted pursuant to the Issuer's 2017 Equity Incentive Plan, effective as of the closing of the Issuer's initial public offering of common stock.